1. Home
  2. BIAF vs WKHS Comparison

BIAF vs WKHS Comparison

Compare BIAF & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • WKHS
  • Stock Information
  • Founded
  • BIAF 2014
  • WKHS 2007
  • Country
  • BIAF United States
  • WKHS United States
  • Employees
  • BIAF N/A
  • WKHS N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WKHS Auto Manufacturing
  • Sector
  • BIAF Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • BIAF 21.4M
  • WKHS 19.5M
  • IPO Year
  • BIAF 2022
  • WKHS N/A
  • Fundamental
  • Price
  • BIAF $1.24
  • WKHS $0.97
  • Analyst Decision
  • BIAF Strong Buy
  • WKHS Sell
  • Analyst Count
  • BIAF 1
  • WKHS 3
  • Target Price
  • BIAF $6.00
  • WKHS $5.75
  • AVG Volume (30 Days)
  • BIAF 102.5K
  • WKHS 5.0M
  • Earning Date
  • BIAF 11-14-2024
  • WKHS 11-19-2024
  • Dividend Yield
  • BIAF N/A
  • WKHS N/A
  • EPS Growth
  • BIAF N/A
  • WKHS N/A
  • EPS
  • BIAF N/A
  • WKHS N/A
  • Revenue
  • BIAF $9,367,785.00
  • WKHS $9,097,780.00
  • Revenue This Year
  • BIAF $302.41
  • WKHS N/A
  • Revenue Next Year
  • BIAF $15.00
  • WKHS $236.05
  • P/E Ratio
  • BIAF N/A
  • WKHS N/A
  • Revenue Growth
  • BIAF 2813.87
  • WKHS N/A
  • 52 Week Low
  • BIAF $1.20
  • WKHS $0.57
  • 52 Week High
  • BIAF $3.62
  • WKHS $8.78
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 36.67
  • WKHS 54.08
  • Support Level
  • BIAF $1.21
  • WKHS $1.02
  • Resistance Level
  • BIAF $1.37
  • WKHS $1.42
  • Average True Range (ATR)
  • BIAF 0.08
  • WKHS 0.20
  • MACD
  • BIAF 0.01
  • WKHS 0.01
  • Stochastic Oscillator
  • BIAF 17.50
  • WKHS 28.88

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: